Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2023-04-05FDA Approved: COSELA — Supplemental Application (G1 Therapeutics, Inc.)
The FDA approved a supplemental application for COSELA (trilaciclib) from G1 Therapeutics, Inc., resulting in updated labeling.